Driving Reduced AIDS-associated Meningo-encephalitis Mortality

NACompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

April 23, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

September 30, 2021

Conditions
AIDS-Related Opportunistic InfectionsMeningo-encephalitisCryptococcal MeningitisBacterial MeningitisTuberculous MeningitisCerebral Toxoplasmosis
Interventions
OTHER

DREAMM

"4 DREAMM interventions to reduce HIV-related meningoencephalitis mortality once access to essential diagnostic tests and medicines:~1. Health system strengthening~2. Delivery of a co-designed education program tailored to frontline healthcare workers~3. Implementation of an algorithm for HIV-related meningoencephalitis~4. Infectious diseases/AHD mentorship and laboratory capacity building"

Trial Locations (5)

Unknown

Hôpital Central Yaoundé, Yaoundé

Kamuzu Central Hospital, Lilongwe

Zomba Central Hospital, Zomba

Amana Hospital, Dar es Salaam

Mwananyamala Hospital, Dar es Salaam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

National Agency for Research on AIDS and Viral Hepatitis (ANRS)

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

National Institute for Medical Research, Tanzania

OTHER_GOV

collaborator

Amana Hospital, Dar es Salaam, Tanzania

UNKNOWN

collaborator

University of North Carolina Project-Malawi (UNC Project), Lilongwe, Malawi

UNKNOWN

collaborator

Kamuzu Central Hospital

OTHER

collaborator

Yaounde Central Hospital

OTHER_GOV

collaborator

Zomba Central Hospital, Zomba, Malawi

UNKNOWN

collaborator

Lighthouse Trust

OTHER

collaborator

Mwananyamala Hospital, Dar es Salaam, Tanzania

UNKNOWN

lead

St George's, University of London

OTHER

NCT03226379 - Driving Reduced AIDS-associated Meningo-encephalitis Mortality | Biotech Hunter | Biotech Hunter